NCT00204698View on ClinicalTrials.gov

Laryngopharyngeal Reflux and Proton Pump Inhibitor (PPI) Treatment

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions
Laryngopharyngeal Reflux
Interventions
DRUG

Aciphex

20 mg of aciphex taken twice daily

Trial Locations (1)

84132

University of Utah, Salt Lake City

All Listed Sponsors
collaborator

PriCara, Unit of Ortho-McNeil, Inc.

INDUSTRY

lead

University of Utah

OTHER

NCT00204698 - Laryngopharyngeal Reflux and Proton Pump Inhibitor (PPI) Treatment | Biotech Hunter | Biotech Hunter